Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

256 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Variable fate of virus-specific CD4(+) T cells during primary HIV-1 infection.
Oxenius A, Fidler S, Brady M, Dawson SJ, Ruth K, Easterbrook PJ, Weber JN, Phillips RE, Price DA. Oxenius A, et al. Among authors: weber jn. Eur J Immunol. 2001 Dec;31(12):3782-8. doi: 10.1002/1521-4141(200112)31:12<3782::aid-immu3782>3.0.co;2-#. Eur J Immunol. 2001. PMID: 11745399 Free article.
Direct ex vivo analysis reveals distinct phenotypic patterns of HIV-specific CD8(+) T lymphocyte activation in response to therapeutic manipulation of virus load.
Oxenius A, Günthard HF, Hirschel B, Fidler S, Weber JN, Easterbrook PJ, Bell JI, Phillips RE, Price DA. Oxenius A, et al. Among authors: weber jn. Eur J Immunol. 2001 Apr;31(4):1115-21. doi: 10.1002/1521-4141(200104)31:4<1115::aid-immu1115>3.0.co;2-9. Eur J Immunol. 2001. PMID: 11298336 Free article.
Primary HIV infection: to treat or not to treat?
Fidler S, Fox J, Porter K, Weber J. Fidler S, et al. Curr Opin Infect Dis. 2008 Feb;21(1):4-10. doi: 10.1097/QCO.0b013e3282f428bf. Curr Opin Infect Dis. 2008. PMID: 18192779 Review.
Discordant outcomes following failure of antiretroviral therapy are associated with substantial differences in human immunodeficiency virus-specific cellular immunity.
Price DA, Scullard G, Oxenius A, Braganza R, Beddows SA, Kazmi S, Clarke JR, Johnson GE, Weber JN, Phillips RE. Price DA, et al. Among authors: weber jn. J Virol. 2003 May;77(10):6041-9. doi: 10.1128/jvi.77.10.6041-6049.2003. J Virol. 2003. PMID: 12719595 Free PMC article. Clinical Trial.
256 results